|
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ENSG00000184363 |
Summary for PKP3 |
Gene summary |
| Gene information | Ensembl ID | ENSG00000184363 | Gene symbol | PKP3 |
| Gene name | plakophilin 3 | |
| HGNC | 9025 | |
| Entrez ID | 11187 | |
| Gene type | protein_coding | |
| Synonyms | PKP3| | |
| UniProtAcc | Q9Y446 |
Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for PKP3 |
AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure.∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
Landscape of gene expressions across multiple cancer types. |
Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| PKP3 | 2.66e+02 | 1.32e+00 | 2.27e-01 | 5.79e+00 | 7.04e-09 | 3.39e-07 | KIRC |
| PKP3 | 1.83e+02 | 1.01e+00 | 2.70e-01 | 3.73e+00 | 1.93e-04 | 2.74e-03 | SARC |
Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| PKP3 | 6.71e+03 | 2.16e+00 | 3.79e-01 | 5.69e+00 | 1.26e-08 | 1.58e-07 | BLCA |
| PKP3 | 6.76e+02 | 1.34e+00 | 4.45e-01 | 3.02e+00 | 2.56e-03 | 5.01e-03 | KIRP |
| PKP3 | 1.80e+04 | 1.52e+00 | 3.69e-01 | 4.12e+00 | 3.83e-05 | 4.59e-04 | ESCA |
| PKP3 | 1.80e+03 | 5.13e+00 | 7.44e-01 | 6.90e+00 | 5.24e-12 | 1.18e-10 | CHOL |
Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| PKP3 | 4.18e+03 | 1.25e+00 | 8.83e-02 | 1.42e+01 | 1.17e-45 | 1.03e-44 | BRCA |
| PKP3 | 7.54e+03 | 1.02e+00 | 3.00e-01 | 3.39e+00 | 7.00e-04 | 2.55e-03 | READ |
Top |
Sex-biased somatic mutation for PKP3 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for PKP3 |
Landscape of DNA methylation across multiple cancer types. |
Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg20992002 | chr11:393328 | CGI:chr11:394257-394619 | promoter,gene body | 3.42e-01 | 2.14e-01 | 2.61e+00 | 9.03e-03 | 2.57e-02 | 1.28e-01 |
| BRCA | cg08616951 | chr11:394545 | CGI:chr11:394257-394619 | promoter,gene body | 3.59e-01 | 2.23e-01 | 2.84e+00 | 4.54e-03 | 1.96e-02 | 1.36e-01 |
| LIHC | cg06267084 | chr11:392508 | CGI:chr11:394257-394619 | promoter | 5.86e-01 | 4.73e-01 | 4.30e+00 | 1.74e-05 | 1.75e-04 | 1.14e-01 |
| SARC | cg18011064 | chr11:394289 | CGI:chr11:394257-394619 | UTR,promoter,exon,gene body | 7.12e-01 | 5.58e-01 | 5.14e+00 | 2.75e-07 | 2.04e-06 | 1.54e-01 |
| SARC | cg09671481 | chr11:394262 | CGI:chr11:394257-394619 | UTR,promoter,exon,gene body | 7.80e-01 | 6.54e-01 | 5.34e+00 | 9.11e-08 | 7.03e-07 | 1.26e-01 |
| SARC | cg08616951 | chr11:394545 | CGI:chr11:394257-394619 | promoter,gene body | 7.04e-01 | 5.39e-01 | 4.44e+00 | 9.07e-06 | 5.73e-05 | 1.64e-01 |
Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| KIRC | cg20992002 | chr11:393328 | CGI:chr11:394257-394619 | promoter,gene body | 5.47e-01 | 7.47e-01 | -5.80e+00 | 6.63e-09 | 5.20e-08 | -1.99e-01 |
| LUSC | cg03547062 | chr11:393606 | CGI:chr11:394257-394619 | promoter,gene body | 4.97e-01 | 8.13e-01 | -4.33e+00 | 1.50e-05 | 5.26e-04 | -3.16e-01 |
| LUSC | cg24982763 | chr11:392562 | CGI:chr11:394257-394619 | promoter | 7.21e-01 | 9.76e-01 | -4.10e+00 | 4.09e-05 | 5.36e-04 | -2.55e-01 |
| LUSC | cg15002541 | chr11:392903 | CGI:chr11:394257-394619 | promoter,gene body | 5.66e-01 | 9.25e-01 | -2.71e+00 | 6.67e-03 | 1.01e-02 | -3.59e-01 |
| LUSC | cg20992002 | chr11:393328 | CGI:chr11:394257-394619 | promoter,gene body | 4.26e-01 | 7.20e-01 | -4.22e+00 | 2.44e-05 | 5.26e-04 | -2.93e-01 |
| LUSC | cg03638937 | chr11:393570 | CGI:chr11:394257-394619 | promoter,gene body | 5.63e-01 | 9.22e-01 | -4.32e+00 | 1.57e-05 | 5.26e-04 | -3.59e-01 |
| LUSC | cg08616951 | chr11:394545 | CGI:chr11:394257-394619 | promoter,gene body | 4.55e-01 | 5.78e-01 | -2.60e+00 | 9.32e-03 | 1.31e-02 | -1.23e-01 |
| LUSC | cg10112265 | chr11:391408 | CGI:chr11:394257-394619 | promoter | 7.67e-01 | 9.13e-01 | -2.64e+00 | 8.23e-03 | 1.19e-02 | -1.46e-01 |
| LUSC | cg06144018 | chr11:391923 | CGI:chr11:394257-394619 | promoter | 7.43e-01 | 9.09e-01 | -3.04e+00 | 2.34e-03 | 4.68e-03 | -1.66e-01 |
| LUSC | cg06267084 | chr11:392508 | CGI:chr11:394257-394619 | promoter | 4.85e-01 | 7.99e-01 | -4.35e+00 | 1.38e-05 | 5.26e-04 | -3.14e-01 |
| LUSC | cg20268054 | chr11:393029 | CGI:chr11:394257-394619 | promoter,gene body | 5.52e-01 | 8.49e-01 | -4.37e+00 | 1.26e-05 | 5.26e-04 | -2.97e-01 |
| LUSC | cg10517281 | chr11:393038 | CGI:chr11:394257-394619 | promoter,gene body | 4.49e-01 | 7.29e-01 | -4.42e+00 | 9.74e-06 | 5.26e-04 | -2.79e-01 |
| LUSC | cg18308516 | chr11:393648 | CGI:chr11:394257-394619 | promoter,gene body | 3.39e-01 | 4.60e-01 | -3.71e+00 | 2.10e-04 | 9.96e-04 | -1.21e-01 |
| LUSC | cg05214427 | chr11:393938 | CGI:chr11:394257-394619 | promoter,gene body | 4.57e-01 | 5.80e-01 | -2.99e+00 | 2.82e-03 | 5.35e-03 | -1.23e-01 |
| LUSC | cg00221668 | chr11:394072 | CGI:chr11:394257-394619 | promoter,gene body | 4.89e-01 | 6.08e-01 | -2.95e+00 | 3.19e-03 | 5.86e-03 | -1.19e-01 |
| LUSC | cg08314660 | chr11:394199 | CGI:chr11:394257-394619 | promoter,gene body | 5.38e-01 | 6.72e-01 | -3.72e+00 | 2.02e-04 | 9.76e-04 | -1.34e-01 |
| COAD | cg15002541 | chr11:392903 | CGI:chr11:394257-394619 | promoter,gene body | 6.95e-01 | 8.79e-01 | -2.12e+00 | 3.37e-02 | 3.70e-02 | -1.85e-01 |
| COAD | cg20992002 | chr11:393328 | CGI:chr11:394257-394619 | promoter,gene body | 4.23e-01 | 5.51e-01 | -3.12e+00 | 1.81e-03 | 3.63e-03 | -1.28e-01 |
| COAD | cg08616951 | chr11:394545 | CGI:chr11:394257-394619 | promoter,gene body | 3.14e-01 | 4.38e-01 | -3.34e+00 | 8.45e-04 | 1.96e-03 | -1.24e-01 |
| BLCA | cg10112265 | chr11:391408 | CGI:chr11:394257-394619 | promoter | 7.06e-01 | 8.90e-01 | -3.15e+00 | 1.65e-03 | 3.38e-03 | -1.84e-01 |
| BLCA | cg06144018 | chr11:391923 | CGI:chr11:394257-394619 | promoter | 7.10e-01 | 8.79e-01 | -3.13e+00 | 1.76e-03 | 3.55e-03 | -1.69e-01 |
| LIHC | cg15002541 | chr11:392903 | CGI:chr11:394257-394619 | promoter,gene body | 6.06e-01 | 8.84e-01 | -2.47e+00 | 1.35e-02 | 1.58e-02 | -2.78e-01 |
| LIHC | cg06267084 | chr11:392508 | CGI:chr11:394257-394619 | promoter | 4.73e-01 | 7.40e-01 | -5.29e+00 | 1.23e-07 | 6.25e-07 | -2.67e-01 |
| LIHC | cg20268054 | chr11:393029 | CGI:chr11:394257-394619 | promoter,gene body | 5.21e-01 | 6.34e-01 | -3.92e+00 | 8.97e-05 | 1.88e-04 | -1.13e-01 |
| LIHC | cg10517281 | chr11:393038 | CGI:chr11:394257-394619 | promoter,gene body | 4.11e-01 | 5.41e-01 | -4.94e+00 | 7.81e-07 | 3.01e-06 | -1.29e-01 |
| LIHC | cg18308516 | chr11:393648 | CGI:chr11:394257-394619 | promoter,gene body | 3.09e-01 | 4.44e-01 | -6.08e+00 | 1.18e-09 | 1.48e-08 | -1.36e-01 |
| KIRP | cg08616951 | chr11:394545 | CGI:chr11:394257-394619 | promoter,gene body | 6.09e-01 | 8.77e-01 | -2.66e+00 | 7.77e-03 | 1.04e-02 | -2.67e-01 |
| KIRP | cg10112265 | chr11:391408 | CGI:chr11:394257-394619 | promoter | 7.20e-01 | 8.81e-01 | -2.87e+00 | 4.14e-03 | 6.07e-03 | -1.61e-01 |
| CHOL | cg03547062 | chr11:393606 | CGI:chr11:394257-394619 | promoter,gene body | 6.66e-01 | 9.63e-01 | -2.80e+00 | 5.09e-03 | 1.63e-02 | -2.97e-01 |
| CHOL | cg15002541 | chr11:392903 | CGI:chr11:394257-394619 | promoter,gene body | 7.52e-01 | 8.98e-01 | -1.99e+00 | 4.65e-02 | 4.65e-02 | -1.47e-01 |
| CHOL | cg20992002 | chr11:393328 | CGI:chr11:394257-394619 | promoter,gene body | 4.49e-01 | 8.10e-01 | -3.46e+00 | 5.30e-04 | 8.63e-03 | -3.62e-01 |
| CHOL | cg03638937 | chr11:393570 | CGI:chr11:394257-394619 | promoter,gene body | 7.49e-01 | 9.59e-01 | -2.14e+00 | 3.25e-02 | 3.87e-02 | -2.11e-01 |
| CHOL | cg08616951 | chr11:394545 | CGI:chr11:394257-394619 | promoter,gene body | 6.00e-01 | 9.04e-01 | -2.58e+00 | 9.87e-03 | 2.15e-02 | -3.04e-01 |
| CHOL | cg10112265 | chr11:391408 | CGI:chr11:394257-394619 | promoter | 7.67e-01 | 9.02e-01 | -1.99e+00 | 4.65e-02 | 4.65e-02 | -1.35e-01 |
| CHOL | cg05214427 | chr11:393938 | CGI:chr11:394257-394619 | promoter,gene body | 6.03e-01 | 8.25e-01 | -2.21e+00 | 2.70e-02 | 3.50e-02 | -2.22e-01 |
| CHOL | cg08314660 | chr11:394199 | CGI:chr11:394257-394619 | promoter,gene body | 6.87e-01 | 8.42e-01 | -2.06e+00 | 3.90e-02 | 4.26e-02 | -1.55e-01 |
Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg03547062 | chr11:393606 | CGI:chr11:394257-394619 | promoter,gene body | 4.63e-01 | 5.67e-01 | -5.89e+00 | 3.97e-09 | 9.17e-09 | -1.04e-01 |
| BRCA | cg24982763 | chr11:392562 | CGI:chr11:394257-394619 | promoter | 9.28e-01 | 7.98e-01 | 1.00e+01 | 1.20e-23 | 8.96e-23 | 1.30e-01 |
| BRCA | cg20992002 | chr11:393328 | CGI:chr11:394257-394619 | promoter,gene body | 3.42e-01 | 4.57e-01 | -7.04e+00 | 1.98e-12 | 5.94e-12 | -1.15e-01 |
| BRCA | cg03638937 | chr11:393570 | CGI:chr11:394257-394619 | promoter,gene body | 5.52e-01 | 6.63e-01 | -5.34e+00 | 9.22e-08 | 1.89e-07 | -1.12e-01 |
| BRCA | cg06144018 | chr11:391923 | CGI:chr11:394257-394619 | promoter | 7.58e-01 | 6.41e-01 | 7.96e+00 | 1.73e-15 | 6.53e-15 | 1.18e-01 |
| BRCA | cg06267084 | chr11:392508 | CGI:chr11:394257-394619 | promoter | 7.39e-01 | 6.10e-01 | 8.83e+00 | 1.03e-18 | 5.01e-18 | 1.29e-01 |
| BRCA | cg05214427 | chr11:393938 | CGI:chr11:394257-394619 | promoter,gene body | 4.17e-01 | 5.58e-01 | -8.51e+00 | 1.72e-17 | 7.59e-17 | -1.41e-01 |
| BRCA | cg00221668 | chr11:394072 | CGI:chr11:394257-394619 | promoter,gene body | 4.52e-01 | 5.81e-01 | -8.85e+00 | 8.96e-19 | 4.38e-18 | -1.29e-01 |
| BRCA | cg08314660 | chr11:394199 | CGI:chr11:394257-394619 | promoter,gene body | 5.03e-01 | 6.08e-01 | -8.69e+00 | 3.64e-18 | 1.70e-17 | -1.05e-01 |
| KIRC | cg09671481 | chr11:394262 | CGI:chr11:394257-394619 | UTR,promoter,exon,gene body | 8.02e-01 | 6.71e-01 | 3.27e+00 | 1.07e-03 | 4.67e-03 | 1.31e-01 |
| KIRC | cg00221668 | chr11:394072 | CGI:chr11:394257-394619 | promoter,gene body | 8.02e-01 | 6.51e-01 | 3.59e+00 | 3.32e-04 | 3.05e-03 | 1.52e-01 |
| LUAD | cg00221668 | chr11:394072 | CGI:chr11:394257-394619 | promoter,gene body | 5.02e-01 | 6.03e-01 | -3.16e+00 | 1.57e-03 | 4.32e-03 | -1.00e-01 |
| LUAD | cg08314660 | chr11:394199 | CGI:chr11:394257-394619 | promoter,gene body | 5.50e-01 | 6.80e-01 | -4.09e+00 | 4.33e-05 | 6.65e-04 | -1.30e-01 |
| THCA | cg08616951 | chr11:394545 | CGI:chr11:394257-394619 | promoter,gene body | 3.31e-01 | 4.46e-01 | -4.47e+00 | 7.87e-06 | 3.60e-05 | -1.14e-01 |
| HNSC | cg05214427 | chr11:393938 | CGI:chr11:394257-394619 | promoter,gene body | 4.76e-01 | 3.72e-01 | 2.23e+00 | 2.59e-02 | 3.23e-02 | 1.05e-01 |
| HNSC | cg00221668 | chr11:394072 | CGI:chr11:394257-394619 | promoter,gene body | 5.05e-01 | 4.04e-01 | 2.38e+00 | 1.75e-02 | 2.55e-02 | 1.01e-01 |
| LIHC | cg08616951 | chr11:394545 | CGI:chr11:394257-394619 | promoter,gene body | 8.16e-01 | 9.48e-01 | -2.92e+00 | 3.53e-03 | 6.10e-03 | -1.33e-01 |
| LIHC | cg08314660 | chr11:394199 | CGI:chr11:394257-394619 | promoter,gene body | 7.20e-01 | 8.49e-01 | -4.30e+00 | 1.68e-05 | 1.01e-04 | -1.29e-01 |
Top |
Exon skipping events with PSI in TCGA for PKP3 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
Landscape of exon skipping events across multiple cancer types. |
Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for PKP3 |
| ∗Please access CAeditome for RNA editing annotation. |
Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for PKP3 |
TFs related to PKP3.∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
PKP3 related gene.∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for PKP3 |
RBPs related to ES in PKP3.∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| LUAD | FMR1 | exon_skip_55371 | 8.26e+00 | 4.88e-03 | 8.66e+00 | 9.89e-01 | Female-biased |
| LUAD | FMR1 | exon_skip_55378 | 8.66e+00 | 9.82e-01 | 8.35e+00 | 1.19e-02 | Male-biased |
| PAAD | FMR1 | exon_skip_55378 | 8.23e+00 | 2.26e-03 | 8.65e+00 | 9.92e-01 | Female-biased |
| HNSC | FMR1 | exon_skip_55378 | 8.68e+00 | 9.89e-01 | 8.26e+00 | 5.19e-03 | Male-biased |
PKP3 related ES.∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs7118400 | chr11:8307391:T:C | - | 0.228532485202937 | 0.0112705817642287 | KIRP | Female-baised eQTL |
| rs56086121 | chr11:7258244:G:C | - | 0.122822214387899 | 0.0249195501411908 | STAD | Female-baised eQTL |
| rs1487862 | chr11:7255311:C:G | - | -0.122539896181356 | 0.0254352362084063 | STAD | Female-baised eQTL |
| rs1008168 | chr11:7256021:T:C | - | 0.122539896181356 | 0.0254352362084063 | STAD | Female-baised eQTL |
| rs10769709 | chr11:6698237:G:A | - | -0.0529563543429408 | 0.0262851292252127 | COAD | Female-baised eQTL |
Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs7103864 | chr11:5123177:T:C | - | -0.064123722000738 | 0.00605788012770394 | COAD | Male-baised eQTL |
| rs11030327 | chr11:3935325:G:C | - | -0.108221468648428 | 0.0109310354468817 | COAD | Male-baised eQTL |
| rs7934497 | chr11:10390170:G:T | - | -0.054606994867067 | 0.0269408070009516 | COAD | Male-baised eQTL |
| rs7105477 | chr11:964271:C:G | - | -0.0538963227379721 | 0.0499625594162508 | COAD | Male-baised eQTL |
Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg05214427 | chr11:393938 | gene,promoter | -0.289256460265024 | 1.98800155880123e-07 | -0.4070449791534595 | 2.0153816852955803e-09 | KIRP |
| cg18011064 | chr11:394289 | gene,exon,promoter,UTR | -0.203915295361424 | 2.86978731942797e-06 | -0.3781006910398062 | 3.132196343971689e-08 | KIRP |
| cg03638937 | chr11:393570 | gene,promoter | -0.291054602367477 | 1.2199274762058e-05 | -0.3683018552227877 | 7.477282886819734e-08 | KIRP |
Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of PKP3 |
Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
| ENSG00000184363 | PKP3 | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
| ENSG00000184363 | PKP3 | C0376358 | Malignant neoplasm of prostate | 1 | CTD_human |